Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132956) titled 'The Exploratory research of Utidelone in the treatment of advanced or metastatic chemotherapy-refractory thymic malignancies' on Sept. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhongshan Hospital, Fudan University
Condition:
thymic malignancies
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-10-15
Target Sample Size: experimental group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=228828
Published by HT Digital Content Services with permission from Health Daily Digest....